About ARMA | ARMA

Sport Rehabilitation is now part of a global profession

BASRaT registered sport rehabilitators are now part of a healthcare profession with international standards, international recognition and international opportunities.

BASRaT has become a full member of the Athletic Training, Therapy and Sport Rehabilitation International Agreement. The Agreement ensures comparable best practices, quality education and professional standards and enables sport rehabilitators to apply for evaluation to work overseas.

This global arrangement plays a key role in optimising care, injury prevention and rehabilitation. It supports the rights of patients and the public to achieve their potential to live well.…

Read more of this article

BCA Launches Patient Charter

The British Chiropractic Association Launches Patient Charter to Members and the Public

In November, the British Chiropractic Association (BCA) launched its new Patient Charter to its members and the general public, as part of the second phase of its ‘Repositioning Project’ which aims to continue the BCA’s mission to be ‘the home of chiropractors who put patients first’. The Patient Charter is a pledge, from BCA chiropractors to their patients, to remind them of the quality care they’ll receive which is laid out in such a way that any patient can start a conversation from it, and any chiropractor can explain it without much labour.…

Read more of this article

Goodbye and good luck to Nita

Nita Parmar has led ARMA’s policy and communications work for over 6 years. It is Nita who has been responsible for compiling this newsletter. In addition to the newsletter Nita has chaired the regular policy and communications meetings and pulled together a consensus on a variety of policy positions from mental health to chronic pain. Nita put ARMA on the twitter map and grew our followers to over 6,500. She has developed and innovated our work on Bone and Joint Week, increasing our engagement and reach with each successive year.…

Read more of this article

ARMA trustee elections 2022

Following the ARMA elections, the AGM welcomed newly elected trustees Dale Webb, CEO of NASS, Ruth Sephton, consultant physiotherapist and Debbie Wilson, young persons’ project manager at NRAS. A full list of our Board is on our website.

At the Board meeting on 26 July 2022, Dirk Vennix was elected as chair and Chris Martey as vice-chair.

Newly elected Chair Dirk Vennix said “Having served on the Board in support of the finance and income generation groups over the last four years, I am honoured to have been chosen to lead the ARMA Board going forward.…

Read more of this article

Anthony Woolf retires from ARMA Board

ARMA bids a fond farewell to Professor Anthony Woolf, who retires from the board of trustees in July.

Tony Woolf served nine years on the ARMA board, two years as vice-chair and seven years as chair. In his role on the board, Tony ardently supported the drive for everyone with MSK conditions to receive appropriate, high-quality interventions to promote their health and well-being in a timely manner. Tony supported ARMA’s aim to engage with policy delivery and practice, better health services for people with MSK and furthering evidence-based MSK pathways, so that there is greater recognition and priority for people’s MSK health.…

Read more of this article

ARMA Trustee elections

Ever thought of becoming a trustee of ARMA?

The ARMA Board consists of nine trustees elected by the membership and up to four co-opted trustees, who are appointed by the Board. Nominations for election to the Board are open until 20 May 2022. You will need a connection with one of our member organisations and to be nominated by a member organisation.

Trustees are responsible for the governance, strategy and management of the charity. They contribute to the strategic development of the organisation and the delivery of its services, taking part in Board meetings and in other activities between meetings as required.…

Read more of this article

ORUK joins ARMA

Last week saw ARMA welcome new member, Orthopaedic Research UK (ORUK), to the alliance.

ORUK funds breakthrough research and education programmes in bone, joint and muscle wellbeing to reduce the burden of poor musculoskeletal health on individuals, workplaces and our health system. The charity was established in 1989 by the orthopaedic surgeon Ronald Furlong FRCS and has become one of the most significant funders of musculoskeletal research, education and innovation in the UK, working alongside many of the UK’s leading MSK professionals and institutions. …

Read more of this article

Arthritis Action Marks 80th Anniversary

2022 marks 80 years of Arthritis Action supporting communities affected by arthritis, with a year of special events and activities. To commemorate this milestone anniversary, the charity introduces a year-long campaign of events and activities recognising the members, partners, volunteers, and organisations who have shown their generous support over the past eight decades.

Some highlighted activities planned for the following months include:

Arthritis Action’s 80 Faces Campaign, celebrating 80 of the charity’s closest supporters and thanking them for their vital help throughout the past 80 years
The #kickupschallenge launch event, a challenge event on social media
An 80 Portraits challenge, with Arthritis Action’s Corporate Partnerships Manager Victoria Clarke, commissioned to paint 80 Portraits over the next twelve months with proceeds donated to the 80th Anniversary fund
A report developed in partnership with YouGov, looking at the state of play and needs of working-age people currently living with arthritis in Great Britain
An ‘80 Miles’ walking challenge with Arthritis Action’s Dietitian and Services Development Manager, Martin Lau

Full information on the campaign plans can be found on Arthritis Action’s 80th Anniversary page.…

Read more of this article

ARMA welcomes new associate member

ARMA is pleased to welcome new associate member AbbVie to its membership.

AbbVie is a research-based biopharmaceutical company discovering and delivering transformational medicines and products in several key therapeutic areas such as immunology. AbbVie invests in research to discover, develop and deliver new medicines. They target diseases with significant unmet need where we can improve the standard of care with innovative new therapies. They aim to create solutions that go beyond treating the illness to have a positive impact on patients’ lives, on societies—and on science itself.…

Read more of this article